Download ![]() |
< Back |
19 Mar 2025 | |
The Company has received recommendation from SEC (Neurology & Psychiatry) of CDSCO to conduct Phase III clinical trials for Cenobamate Tablets | |
View all announcements for Bajaj Healthcare Ltd | Source: BSE India |